These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9420575)

  • 1. Low-molecular-weight heparin for PE.
    Grimm KJ; French L
    J Fam Pract; 1997 Dec; 45(6):467-8. PubMed ID: 9420575
    [No Abstract]   [Full Text] [Related]  

  • 2. [Conventional or low molecular weight heparin in the treatment of venous thromboembolic disease?].
    Ruiz Manzano J; Monreal M
    Med Clin (Barc); 1998 Nov; 111(18):697-9. PubMed ID: 9887434
    [No Abstract]   [Full Text] [Related]  

  • 3. Outpatient treatment of patients with pulmonary embolism.
    Wells PS; Büller HR
    Semin Vasc Med; 2001 Nov; 1(2):229-34. PubMed ID: 15199507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low molecular weight heparin and pulmonary embolism.
    Nardini S
    Monaldi Arch Chest Dis; 1996 Jun; 51(3):247-9. PubMed ID: 8766203
    [No Abstract]   [Full Text] [Related]  

  • 5. Pulmonary embolism.
    Schrijvers D; Van den Brande J; Vermorken JB
    N Engl J Med; 1998 Nov; 339(21):1555; author reply 1557. PubMed ID: 9841332
    [No Abstract]   [Full Text] [Related]  

  • 6. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials.
    Wan S; Quinlan DJ; Agnelli G; Eikelboom JW
    Circulation; 2004 Aug; 110(6):744-9. PubMed ID: 15262836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical potential of low molecular weight heparins.
    Messmore HL
    Semin Thromb Hemost; 1989 Oct; 15(4):405-8. PubMed ID: 2554501
    [No Abstract]   [Full Text] [Related]  

  • 8. [The prevention of thromboembolic disease in medical patients: heparin-calcium or low-molecular-weight heparin?].
    de los Santos-Sastre S
    An Med Interna; 1993 Sep; 10(9):465-6. PubMed ID: 8218806
    [No Abstract]   [Full Text] [Related]  

  • 9. Is there enough evidence that low-molecular-weight heparin is superior to unfractionated heparin in pulmonary embolism?
    Sharma GK
    Arch Intern Med; 2000 Jul; 160(13):2065-6. PubMed ID: 10888989
    [No Abstract]   [Full Text] [Related]  

  • 10. An objective evaluation of the clinical potential of low molecular weight heparins in the prevention of thromboembolism.
    Haas S; Blümel G
    Semin Thromb Hemost; 1989 Oct; 15(4):424-34. PubMed ID: 2554503
    [No Abstract]   [Full Text] [Related]  

  • 11. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 2. Subcutaneous heparin is as good as low-molecular-weight heparin in the acute treatment of thrombo-embolic disease.
    Munro A; English C
    Emerg Med J; 2008 May; 25(5):287-9. PubMed ID: 18434466
    [No Abstract]   [Full Text] [Related]  

  • 12. [Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes].
    MMW Fortschr Med; 2003 Jun; 145(24):56. PubMed ID: 12866309
    [No Abstract]   [Full Text] [Related]  

  • 13. Outpatient treatment of pulmonary embolism with dalteparin.
    Kovacs MJ; Anderson D; Morrow B; Gray L; Touchie D; Wells PS
    Thromb Haemost; 2000 Feb; 83(2):209-11. PubMed ID: 10739374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Deep venous thrombosis--treatment].
    Fries R; Böhm M
    Dtsch Med Wochenschr; 2003 May; 128(18):999-1002. PubMed ID: 12721879
    [No Abstract]   [Full Text] [Related]  

  • 15. Initial treatment of venous thromboembolism.
    Kearon C
    Thromb Haemost; 1999 Aug; 82(2):887-91. PubMed ID: 10605798
    [No Abstract]   [Full Text] [Related]  

  • 16. Thromboembolism.
    Fitzmaurice D; Hobbs FD; McManus R
    Clin Evid; 2002 Jun; (7):199-213. PubMed ID: 12230644
    [No Abstract]   [Full Text] [Related]  

  • 17. When can the patient with deep venous thrombosis begin to ambulate?
    Aldrich D; Hunt DP
    Phys Ther; 2004 Mar; 84(3):268-73. PubMed ID: 14984299
    [No Abstract]   [Full Text] [Related]  

  • 18. Low-molecular-weight heparin in the treatment of pulmonary embolism.
    Ageno W; Turpie AG
    Semin Vasc Surg; 2000 Sep; 13(3):189-93. PubMed ID: 11005462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of unfractionated heparin and low molecular weight heparin in pulmonary thromboembolism: meta-analysis].
    Zhai ZG; Wang C; Liu YM; Qin ZQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun; 26(3):221-6. PubMed ID: 15266820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism: a meta-analysis.
    Couturaud F; Julian JA; Kearon C
    Thromb Haemost; 2001 Oct; 86(4):980-4. PubMed ID: 11686355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.